Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03083730 · ClinicalTrials.gov registry record · NA
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
A NA study, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03083730: Completed NA study, sponsored by Rockefeller University.
NCT03083730 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03083730, a NA study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Atopic dermatitis (eczema) is a chronic inflammatory disease that causes significant morbidity and is now known to be associated with cardiovascular disease. Research such as this will add to the understanding of the skin as a contributor to systemic inflammation, and it is important to clarify whether skin-only treatment can alleviate systemic inflammation, and potentially influence cardiovascular risk factors.
Primary Outcome
Change from baseline of inflammatory and cardiovascular risk proteins in serum of atopic dermatitis patients during treatment with NB-UVB.
Interventions
- OTHER Narrow band UVB treatment (NB-UVB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-07-19 |
| Est. Completion | 2020-02-24 |
| Phase | NA |
What the finished NCT03083730 record still lists
NCT03083730 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Narrow band UVB treatment (NB-UVB) is the first listed.
NCT03083730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03083730 about?
NCT03083730 is a clinical study titled "Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis". Atopic dermatitis (eczema) is a chronic inflammatory disease that causes significant morbidity and is now known to be associated with cardiovascular disease. Research such as this will add to the understanding of the skin as a contributor to systemic inflammation, and it is important to clarify whet...
What is the current status of trial NCT03083730?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2017-07-19. Estimated completion is 2020-02-24.
What interventions are being tested in trial NCT03083730?
The interventions under investigation include: Narrow band UVB treatment (NB-UVB) (OTHER).
Who is sponsoring clinical trial NCT03083730?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03083730's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI